Clinical impact of very high‐power‐short‐duration catheters on biomarkers after atrial fibrillation ablation

Documenti analoghi

• Malnutrition and risks of atrial fibrillation recurrence after catheter ablation
  di: Phuuwadith Wattanachayakul, et al.
  Pubblicazione: (2024)
• The association between hyperuricemia and atrial fibrillation recurrence after catheter ablation
  di: Hirotsuna Oseto, et al.
  Pubblicazione: (2024)
• Editorial to “Efficacy of an alternative positioning of intracardiac defibrillation catheters in atrial fibrillation ablation”
  di: Hideharu Okamatsu, et al.
  Pubblicazione: (2025)
• Editorial to “The association between hyperuricemia and atrial fibrillation recurrence after catheter ablation”
  di: Ugur Canpolat
  Pubblicazione: (2024)
• Clinical and pathophysiologic determinants of catheter ablation outcome in hypertrophic cardiomyopathy with atrial fibrillation
  di: Jae‐Hyuk Lee, et al.
  Pubblicazione: (2024)